|
Calculating Nitrosamine Limits (MasterClass)
|
|
4
|
1641
|
March 19, 2024
|
|
N-nitroso cyclamate
|
|
9
|
371
|
March 15, 2024
|
|
Application of duplex sequencing to evaluate mutagenicity -Pub
|
|
1
|
206
|
March 14, 2024
|
|
🇪🇺 EDQM - top 10 deficiencies observed in new CEP applications
|
|
0
|
491
|
March 14, 2024
|
|
Lack of effect of antioxidants on Biopharmaceutics Classification System (BCS) Class III drug permeability -Pub
|
|
1
|
333
|
March 13, 2024
|
|
NDMA evaluation in battery of in vivo Genotoxicity assays once again leading to AI much greater than 96 ng/day
|
|
0
|
173
|
March 13, 2024
|
|
USP User Forum in 🇨🇦 Toronto
|
|
0
|
133
|
March 12, 2024
|
|
🌎 Our community in the world!
|
|
0
|
315
|
February 6, 2024
|
|
Open-Access Software for Chemical Read-Across
|
|
0
|
192
|
March 12, 2024
|
|
MEGLUMINE (Methylglucamine)
|
|
15
|
1774
|
March 12, 2024
|
|
LOQ for small nitrosamines
|
|
1
|
201
|
March 11, 2024
|
|
🇪🇺 OMCL Network published NDSRIs Analytical Methods
|
|
1
|
685
|
March 11, 2024
|
|
Simple and Practical Method for the Quantitative High-Sensitivity Analysis of N-Nitroso Duloxetine in Duloxetine Drug Products Utilizing LC-MS/MS
|
|
0
|
279
|
March 9, 2024
|
|
AI limit for N-Nitroso Losartan
|
|
4
|
307
|
March 9, 2024
|
|
USP-NF General Notices Revision open for Comments
|
|
0
|
607
|
March 7, 2024
|
|
Read-across Masterclass: How To Facilitate Your Acceptable Intake Limit Setting For Nitrosamines
|
|
0
|
254
|
March 7, 2024
|
|
Updated: IPEC Position Paper on Role of Excipients in Determining N-Nitrosamine Risks for Drug Products
|
|
3
|
633
|
March 7, 2024
|
|
Regulatory Differences between EMA and FDA on Nitrosamines
|
|
0
|
174
|
March 6, 2024
|
|
Define MDD to calculate limit
|
|
39
|
11103
|
March 6, 2024
|
|
Nitrosamines evaluation in transdermal patches
|
|
10
|
1372
|
March 5, 2024
|
|
Ribociclib Succinate NDSRIs limit clarification related
|
|
6
|
519
|
March 5, 2024
|
|
Nitrite Scavengers in Solution and Solid State
|
|
12
|
2075
|
March 5, 2024
|
|
MCC with nitrite levels of 0.1 ppm or less
|
|
4
|
727
|
March 4, 2024
|
|
Role of Carbonyl Compounds for N-Nitrosamine Formation during Nitrosation: Kinetics and Mechanisms
|
|
0
|
276
|
March 2, 2024
|
|
NEWS! New USP Community on qNMR
|
|
0
|
195
|
March 1, 2024
|
|
🇲🇽 Conferencia USP Nitrosaminas en México presencial 21-Marzo
|
|
3
|
476
|
February 29, 2024
|
|
Entidades regulatorias y su postura en el análisis de nitrosaminas en estudios de estabilidad de preparados farmacéuticos
|
|
0
|
152
|
February 28, 2024
|
|
Quality Officer Call for a New approach to Reduce Post Approval Complexity
|
|
0
|
233
|
February 28, 2024
|
|
Regulatory Highlights(OPR&D)
|
|
14
|
1698
|
February 28, 2024
|
|
Is it possible to observe N-nitrosamines formation from oximes? Do you have any reference to support the risk assessment for nitrosamine formation from the reaction of these functional groups in the presence of nitrosating agents? Thank you
|
|
2
|
211
|
February 27, 2024
|